Skip to content

Somatropin

Also called rhGH, Genotropin, Norditropin

Subcutaneous (under the skin)Product label

Research reference

Product label

Genotropin individualized schedules

Adult non-weight-based option: about 0.2 mg/day, adjusted by response and IGF-I

Adult adjustments generally every 1–2 months; childhood schedules differ

Genotropin product label ↗

When results may show

When change was measured
IGF-I, side effects and the underlying condition guide review. Childhood weekly totals are not adult daily doses.
When to assess
Adult adjustments generally every 1–2 months; childhood schedules differ
Conditions and limitations
Adult GH deficiency or specified childhood growth conditions; schedules differ. Use the prescribed brand/device and clinical plan. Do not turn the approximate adult label option into a generic starter or convert IU without the exact product instructions.
When to stop
Use the exact product's clinical monitoring and stopping instructions. A supply interval is not a stop date; severe or persistent reactions need prompt clinical review.

Research timing is descriptive, not a promise or personal instruction. A severe or persistent reaction needs prompt clinical review. This is not medical advice.

Vial arithmetic

Published research contexts for Somatropin describe 0.2–0.4 mg per administration. Descriptive only, not a recommendation.

Modelled level — every day

1× is the peak after a single dose.

Steady-state peak
1.00× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
15hours

About five half-lives

Administrations
7/ week

Where these numbers come from

  • Genotropin product labelUse the prescribed brand/device and clinical plan. Do not turn the approximate adult label option into a generic starter or convert IU without the exact product instructions.

Next steps